Source: Annual Congress 2005 - From mice to men: acute lung injury
Disease area: Airway diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
C. Gessner, H. Dihazi, S. Brettschneider, S. Hammerschmidt, H. Kuhn, A. Gillissen, K. Eschrich, H. Wirtz (Leipzig, Goettingen, Germany). Correlation of ventilatory parameters and disease severity with detection rate of cytokeratins in exhaled breath condensate. Eur Respir J 2005; 26: Suppl. 49, 3590

Member's Comments

No comment yet.

Related content which might interest you: Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006 Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Reproducibility of exhaled breath condensate markers Source: Eur Respir J 2008; 32: Year: 2008 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 pH in exhaled breath condensate of patients with stable COPD: associations with disease severity and pulmonary function tests Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Exhaled breath condensate pH standardised for CO2 partial pressure Source: Eur Respir J 2007; 29: 496-501 Year: 2007 Possible use of exhaled breath condensate (EBC) for continuous monitoring of lung inflammation in artificial ventilation Source: Eur Respir J 2002; 20: Suppl. 38, 85s Year: 2002 The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003 Comparison of two devices and two breathing patterns for exhaled breath condensate sampling Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Changes in ventilation and respiratory impedance after sampling of exhaled breath condensate (EBC) in pigs Source: Eur Respir J 2002; 20: Suppl. 38, 175s Year: 2002 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008